Fan Zhang, Ph.D., sees artificial intelligence as a pathway to finding an effective way to combat an intractable enemy: ...

Rheumatoid arthritis is an autoimmune condition that causes the bodys immune system to attack the joints causing pain ...

Biologic disease-modifying antirheumatic drugs (bDMARDs) do not appear to negatively impact fertility among women with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), according to study ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Treatment of RA and AS is similar, but there are key differences. In general, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics, corticosteroids, and JAK inhibitors may help. Your doctor ...

With nearly 1.5 million people suffering from rheumatoid and juvenile arthritis in the United States, researchers at Shriners Children's St. Louis have discovered a revolutionary way to potentially ...

Janus kinase inhibitor cycling may be more effective than switching to bDMARDs among patients with RA who had an inadequate response to initial JAK inhibitor therapy.

Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.

Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.

Weight loss from glucagon-like peptide 1 agonists clearly alleviates knee osteoarthritis pain, but other recently published data give pause regarding possible long-term adverse effects.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.